Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edgell BJ"'
Autor:
Chiu TA; A human factors specialist at Sinai Health in Toronto, ON. She specializes in human-centred design methods and is involved in mitigation of clinical and enterprise risks, clinical space redesign and new technology implementation at Mount Sinai Hospital and Bridgepoint Active Healthcare., Jeon J; The lead for the human factors team at Sinai Health in Toronto, ON, where she pioneers the application of human-centred design methods to health technology and facility redevelopment projects. Her team supports various high-risk system redesign initiatives across the organization., Edgell BJ; The manager of Facility Operations at The Centre for Phenogenomics (TCP) and Sinai Health in Toronto, ON. She is responsible for the daily operations of the research vivarium at TCP and for facilitating research activity and services for the research personnel of the Lunenfeld-Tanenbaum Research Institute and SickKids Research Institute., Bassi G; The director of the Medical Device Reprocessing Department at Mount Sinai Hospital in Toronto, ON, where he supports daily operations and the planning and redevelopment of the future expansion of the department. He sits on the CSA Z314-18 Medical Device Reprocessing Standards Technical Committee and was the provincial director of Education for the Medical Device Reprocessing Association of Canada. He can be reached by e-mail at garry.bassi@sinaihealth.ca.
Publikováno v:
Healthcare quarterly (Toronto, Ont.) [Healthc Q] 2021 Jan; Vol. 23 (4), pp. 35-38.
Autor:
Turgeon, Nathalie1 (AUTHOR), Pagé, Mélissa1 (AUTHOR), Robillard, Justin1 (AUTHOR), Goulet, Véronique1 (AUTHOR), Bahloul, Ali2,3 (AUTHOR), Brochot, Clothilde2,3 (AUTHOR), Saidi, Mohamed Nejib2 (AUTHOR), Dumont-Leblond, Nathan1 (AUTHOR), Duchaine, Caroline1,4,5 (AUTHOR) Caroline.Duchaine@bcm.ulaval.ca
Publikováno v:
PLoS ONE. 1/23/2023, Vol. 17 Issue 1, p1-16. 16p.
Autor:
Albert SE; Research Institute, The Hospital for Sick Children, University of Toronto, Ontario, Canada., McKerlie C, Pester A, Edgell BJ, Carlyle J, Petric M, Chamberlain JW
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 1997 Aug 01; Vol. 159 (3), pp. 1393-403.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hall, Monte D.1,2, Rewers-Felkins, Kathleen A.1,3, Quinlin, Imelda S.1,3, Wright, Stephen E.1,2,3 stephen.wright@ttuhsc.edu, Zhenyao Wang
Publikováno v:
OncoImmunology. Feb2013, Vol. 2 Issue 2, pe23335-1-e23335-7. 7p.
Autor:
Nguyen, H.1, Hay, J.1,2, Mazzulli, T.1, Gallinger, S.3,4, Sandhu, J.3, Teng, Y.-T. A.5, Hozumi, N.6,7
Publikováno v:
Clinical & Experimental Immunology. Oct2000, Vol. 122 Issue 1, p85-93. 9p.
Autor:
Böcher, W., Reisner, Y.
Publikováno v:
Monographs in Virology; 2005, Vol. 25, p146-160, 15p
Autor:
von Weizsäcker, F., Roggendorf, M.
Viral hepatitis B or C is the most common cause of chronic liver disease worldwide and accounts for about 80% of all hepatocellular carcinoma cases. Thus, combating viral hepatitis remains one of the most pressing public health issues today. Animal m